Pre-Cure is transforming cancer care with its 3D-TumorX platform — a multifunctional Tumor-on-a-Chip (TOC) that enables rapid ex vivo testing of therapy responses under conditions that closely mimic the human body and tumor microenvironment. The platform can simultaneously assess a broad range of therapies and deliver comprehensive biological insights into tumor behavior and treatment response.